Preliminary safety, efficacy and pharmacokinetics (PK) results of KN026, a HER2 bispecific antibody in patients (pts) with HER2-positive metastatic breast cancer.

被引：0

作者：

Ji, Dongmei

Zhang, Jian

Shen, Weina

Du, Yiqun

Xu, June

Yang, Jing

Luo, Xin

Kong, Paul

Yang, Fei

Hu, Xi-Chun

机构：

[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China

[2] Alphamab Oncol, Suzhou, Peoples R China

[3] Fudan Univ, Canc Hosp, Shanghai, Peoples R China

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1041

引用

页数：2